Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 2
2001 1
2002 1
2003 1
2004 1
2006 2
2007 3
2008 3
2009 2
2010 1
2013 1
2014 2
2015 3
2017 1
2018 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.
Van Cutsem E, Bang YJ, Feng-Yi F, Xu JM, Lee KW, Jiao SC, Chong JL, López-Sanchez RI, Price T, Gladkov O, Stoss O, Hill J, Ng V, Lehle M, Thomas M, Kiermaier A, Rüschoff J. Van Cutsem E, et al. Among authors: stoss o. Gastric Cancer. 2015 Jul;18(3):476-84. doi: 10.1007/s10120-014-0402-y. Epub 2014 Jul 20. Gastric Cancer. 2015. PMID: 25038874 Free PMC article. Clinical Trial.
[ISH-based HER2 diagnostics].
Rüschoff J, Nagelmeier I, Jasani B, Stoss O. Rüschoff J, et al. Among authors: stoss o. Pathologe. 2020 Nov;41(6):606-613. doi: 10.1007/s00292-020-00841-5. Pathologe. 2020. PMID: 33001242 Review. German.
ISH-based HER2 diagnostics.
Rüschoff J, Nagelmeier I, Jasani B, Stoss O. Rüschoff J, et al. Among authors: stoss o. Pathologe. 2020 Dec 21. doi: 10.1007/s00292-020-00878-6. Online ahead of print. Pathologe. 2020. PMID: 33346874 Review. English.
Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.
Scheel AH, Baenfer G, Baretton G, Dietel M, Diezko R, Henkel T, Heukamp LC, Jasani B, Jöhrens K, Kirchner T, Lasitschka F, Petersen I, Reu S, Schildhaus HU, Schirmacher P, Schwamborn K, Sommer U, Stoss O, Tiemann M, Warth A, Weichert W, Wolf J, Büttner R, Rüschoff J. Scheel AH, et al. Among authors: stoss o. Histopathology. 2018 Feb;72(3):449-459. doi: 10.1111/his.13375. Epub 2017 Nov 21. Histopathology. 2018. PMID: 28851100
Emerging therapeutic targets in chronic heart failure: part I.
Roenicke V, Leclair S, Hoffmann A, Becker M, Szado T, Kirsch T, Stoss O, Navé BT, Henkel T. Roenicke V, et al. Among authors: stoss o. Expert Opin Ther Targets. 2002 Dec;6(6):649-58. doi: 10.1517/14728222.6.6.649. Expert Opin Ther Targets. 2002. PMID: 12472378 Review.
[ErbB2 diagnostics in breast cancer--an update].
Rüschoff J, Nagelmeier I, Hofmann M, Henkel T, Stoss O. Rüschoff J, et al. Among authors: stoss o. Pathologe. 2009 Mar;30(2):147-55. doi: 10.1007/s00292-009-1126-3. Pathologe. 2009. PMID: 19214513 German.
Emerging therapeutic targets in chronic heart failure: part II.
Roenicke V, Leclair S, Hoffmann A, Becker M, Szado T, Kirsch T, Stoss O, Navé BT, Henkel T. Roenicke V, et al. Among authors: stoss o. Expert Opin Ther Targets. 2003 Feb;7(1):49-59. doi: 10.1517/14728222.7.1.49. Expert Opin Ther Targets. 2003. PMID: 12556202 Review.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page